209 related articles for article (PubMed ID: 21075410)
1. [Ocular myasthenia: diagnosis and treatment].
Stojkovic T; Béhin A
Rev Neurol (Paris); 2010 Dec; 166(12):987-97. PubMed ID: 21075410
[TBL] [Abstract][Full Text] [Related]
2. Ocular myasthenia: diagnosis, treatment, and pathogenesis.
Kusner LL; Puwanant A; Kaminski HJ
Neurologist; 2006 Sep; 12(5):231-9. PubMed ID: 16990734
[TBL] [Abstract][Full Text] [Related]
3. Essentials in the management of myasthenia gravis.
Galdi AP
Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
[TBL] [Abstract][Full Text] [Related]
4. An atypical course of myasthenia gravis.
Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
7. [Ocular myasthenia].
Huber A
Klin Monbl Augenheilkd; 1985 Mar; 186(3):158-60. PubMed ID: 3999598
[TBL] [Abstract][Full Text] [Related]
8. [Pseudoparalytic myasthenia gravis. Diagnostic and therapeutic aspects in 60 separate cases].
Mumenthaler M; Lütschg J
Schweiz Arch Neurol Neurochir Psychiatr; 1976; 118(1):23-56. PubMed ID: 981976
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
Gajdos P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
[TBL] [Abstract][Full Text] [Related]
10. Thymectomy in the treatment of ocular myasthenia gravis.
Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of ocular myasthenia (author's transl)].
Huber A
Klin Monbl Augenheilkd; 1977 Dec; 171(6):889-95. PubMed ID: 203742
[TBL] [Abstract][Full Text] [Related]
12. [Ocular myasthenia: a diagnostic and management challenge--a review].
Langmann A; Lindner S; Koch M; Diez J
Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of myasthenia gravis. Experience 1974-1992].
Rey RD; Buzzi AE; Astudillo MA; Díaz G; Losavio A; Muchnik S; Sanz OP; Sica RE
Medicina (B Aires); 1995; 55(1):11-20. PubMed ID: 7565029
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
Nicholson GA; Griffiths LR
Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
[TBL] [Abstract][Full Text] [Related]
15. Ocular aspects of myasthenia gravis.
Barton JJ; Fouladvand M
Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of autoimmune myasthenia].
Pénisson-Besnier I
Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
[TBL] [Abstract][Full Text] [Related]
17. Pearls: myasthenia.
Benatar M
Semin Neurol; 2010 Feb; 30(1):35-7. PubMed ID: 20127579
[TBL] [Abstract][Full Text] [Related]
18. [Juvenile myasthenia gravis].
Papazian O; Alfonso I
Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of pediatric ocular myasthenia gravis.
Ortiz S; Borchert M
Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapies in myasthenia gravis.
Sanders DB; Evoli A
Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
